Diebold Nixdorf, Incorporated DBD
62.72
0.25
0.40%
as of 25 Sep
- Market cap
- $2.1B
- P/E
- 20.2×
Follow DBD
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
41.03 | 25.81 | 25.23 | 27.34 |
P/S ratio |
0.56 | 0.66 | 0.69 | 0.76 | |
P/FCF ratio |
9.07 | 10.45 | 10.44 | 13.80 | |
P/Operating CF |
55.66 | 11.49 | 83.53 | (215.05) | |
P/B ratio |
1.87 | 2.26 | 2.58 | 3.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.74 | 0.79 | 0.83 | 0.93 | |
EV/EBITDA |
8.02 | 8.04 | 8.53 | 9.50 | |
EV/Operating CF |
9.79 | 10.04 | 10.15 | 13.13 | |
EV/FCF |
11.92 | 12.64 | 12.67 | 16.91 | |
Quick Ratio |
0.68 | 0.79 | 0.69 | 0.69 | |
Current Ratio |
1.36 | 1.30 | 1.28 | 1.27 | |
Net Debt/EBITDA |
6.11 | 4.55 | 8.60 | 7.36 | |
Debt/Assets |
25.08% | 24.35% | 24.53% | 25.23% | |
Debt/Equity |
0.84 | 0.85 | 0.92 | 0.97 | |
Asset Turnover |
0.97 | 1.03 | 1.03 | 1.04 | |
Operating CF/Net income |
0.91 | 4.39 | 6.34 | (0.88) | |
Capex/Depreciation |
(0.39) | (0.67) | (0.33) | (0.47) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.15% | 1.93% | 2.48% | 2.20% | |
Selling, General and Administrative Expense of Revenue |
15.96% | 15.90% | 17.63% | 17.44% | |
Intangible Assets out of Total Assets |
0.39 | 0.37 | 0.36 | 0.37 | |
Share Based Compensation of Revenue |
0.32% | 0.25% | 0.36% | 0.45% | |
Graham Net Nets |
(0.43) | (0.39) | (0.38) | (0.36) | |
Graham Number |
30.87 | 42.15 | 44.35 | 44.57 | |
Earnings Yield |
2.44% | 3.87% | 3.96% | 3.66% | |
Free Cash Flow Yield |
11.03% | 9.57% | 9.58% | 7.25% | |
Revenue per Share |
25.90 | 30.01 | 25.41 | 27.06 | |
Operating CF per Share |
1.02 | 5.91 | 0.90 | (0.40) | |
Capex per Share |
(0.35) | (0.59) | (0.31) | (0.44) | |
Free Cash Flow per Share |
0.67 | 5.32 | 0.59 | (0.84) | |
Cash per Share |
7.67 | 11.32 | 10.64 | 8.21 | |
Shareholders Equity per Share |
30.48 | 30.02 | 29.24 | 28.39 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
30.48 | 30.02 | 29.24 | 28.39 | |
Free Cash Flow |
24.50 | 195.70 | 20.70 | (28.90) | |
Working Capital |
458.30 | 415.30 | 396.10 | 361.00 | |
Capital Expenditures |
(12.90) | (21.80) | (11.00) | (15.30) | |
Net Current Asset Value |
(889.70) | (962.80) | (1,003.60) | (1,048.30) | |
EV/EBIT |
13.62 | 12.48 | 13.11 | 14.56 | |
Capex to Sales |
0.01 | 0.02 | 0.01 | 0.02 | |
Net Profit Margin |
4.35% | 4.49% | 0.56% | 1.67% | |
Price to Operating Income |
10.37 | 10.32 | 10.80 | 11.87 | |
| Other line items | |||||
Average Receivables |
622.75 | 628.65 | 599.80 | 625.80 | |
Average Payables |
470.35 | 445.65 | 466.05 | 468.75 | |
Average Inventory |
620.40 | 524.55 | 553.05 | 584.95 | |
Average Assets |
3,812.55 | 3,698.95 | 3,727.75 | 3,738.25 | |
Average Common Equity |
1,094.15 | 1,021.50 | 1,008.60 | 1,040.75 |
Columns are period end dates